Is much less regulation by the Meals and Drug Administration good for the biotech business? Do vaccine makers like Pfizer have a goal on their again now? And can the “Make America Wholesome Once more” motion helmed by Robert F. Kennedy Jr. dampen the weight problems drug market?
We focus on all that and extra on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. To dig into how the election outcomes may have an effect on all issues biopharma, we introduced on three visitors for this episode: Lizzy Lawrence, STAT’s FDA reporter, Baird analyst Brian Skorney, and longtime biotech govt Daphne Zohar.
For extra on what Trump’s second time period means for the FDA, go right here; to study the important thing figures within the MAHA motion, go right here; and for extra on how leaders within the biopharma business have reacted to the election, go right here.
Ensure to join “The Readout LOUD” on Apple Podcasts, Spotify, TuneIn, or wherever you get your podcasts.
